Damien Lamendola is a distinguished business leader with an extensive background in the healthcare industry. Appointed to the Board of Marpai on April 1, 2021, Lamendola brings a wealth of experience and expertise to his new role as the Chief Executive Officer.

Lamendola is the founder of Continental Benefits in 2013, where he served as the Chief Executive Officer until 2019. His visionary leadership and strategic acumen were pivotal in establishing Continental Benefits as a prominent player in the industry.

Since March 2002, Lamendola has held the position of President at HillCour Holding Corporation, formerly known as Welldyne Holding Corp. His tenure at HillCour Holding Corporation spans several years, during which he has meticulously overseen the strategic operations of multiple operating companies within the healthcare sector, showcasing his adeptness in steering complex organizations towards success.

Apart from his role as President, Lamendola has also been an integral part of the board of HillCour Holding Corporation since 2017, demonstrating his commitment to guiding and shaping the company’s trajectory. His board memberships in WellDyneRx, LLC and HillCour Investment Fund, LLC since 2017 further underscore his involvement and influence within these organizations.

Lamendola’s educational background is just as impressive as his professional achievements. He earned a Bachelor of Science degree from McNeese State University and later pursued an M.B.A. from Washington University, equipping him with a solid foundation in business management and strategic leadership.

With a track record marked by innovation and success in the healthcare industry, Lamendola’s appointment as the CEO of Marpai heralds an era of strategic growth and visionary leadership for the company. His proven ability to navigate and lead complex healthcare organizations positions him as a formidable force in driving Marpai’s success in the industry.